Show side menu

WEWINBRD: Production and validation of host defense peptides-based drugs for the treatment of Bovine Respiratory Disease

Starting date: 01/06/2020 End date: 31/05/2023
Programme: Ruminant Production

Financing entities:

WEWINBRD emerges from an effort to develop an effective broad spectrum treatment to control the BRD causing agents, using new proteinaceous drugs based on host defense peptides (HDPs), which have previously shown bactericidal activities against virus, bacteria and fungi.